Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SY-005 Injection Phase IIa Study in Sepsis
CTR20211345Phase 2Completed
- Sponsor
- Suzhou Yabao Pharmaceutical Research and Development
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of annexin a5 in sepsis, sponsored by Suzhou Yabao Pharmaceutical Research and Development. Started Jun 2021; status: completed.
02
Drugs
annexin a5
03
Conditions
sepsis
Beyond the preview
Go deeper on CTR20211345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211345.